High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma.

Ann Hematol · 2019 · PMC6423309 · PMID 30715566

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

a marked trendP < 0.001actually significant

By multivariate analysis, the clinical response to high-dose etoposide was demonstrated to have a significant impact or a marked trend toward a higher CR achievement (OR, 2.331 (1.481–3.891), P < 0.001), longer PFS (HR, 0.210 (0.069–0.643), P = 0.006), and OS (HR, 0.183 (0.062–0.543), P = 0.002).

also in 422 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.